期刊文献+

特发性血小板减少性紫癜患儿血小板生成素及其受体基因转录水平的研究 被引量:4

The level of serum thrombopoietin and its receptor mRNA in platelets in children with idiopathic thrombocytopenic purpura
原文传递
导出
摘要 目的 探讨急性特发性血小板减少性紫癜 (AITP)患儿血小板生成素 (TPO)及血小板TPO受体c MPLmRNA基因转录水平变化的意义。方法 采用ELISA法检测血清TPO、血小板相关抗体 (PAIgG)水平 ;半定量RT PCR法检测外周血血小板c MPLmRNA的相对量。结果 AITP患儿初治时血浆TPO水平增高 ,血小板c MPLmRNA较低 ;经大剂量甲基强的松龙冲击治疗后 ,伴随血小板计数增高 ,血清TPO水平逐渐下降 ,血小板c MPLmRNA增高 ,且与PAIgG呈负相关。结论 血小板数可调控血清TPO水平 ;AITP患儿初诊时c MPLmRNA基因转录下调 ,可能导致骨髓巨核细胞成熟障碍 ,血小板生成减少 ,是AITP发病的重要因素之一。 Objective To explore the significance of serum thrombopoietin (TPO) and its receptor (c MPL) mRNA changes in platelets in children with acute idiopathic thrombocytopenic purpura (AITP). Methods The serum TPO and platelet associated IgG (PAIgG) were detected by ELISA. The mRNA levels of c MPL in platelets were determined by semi quantitative reverse transcription polymerase chain reaction (RT PCR). Results Before treatments in chidren with ITP the serum TPO levels were mildly elevated and c MPL mRNA levels in platelets were decreased, when compared with normal controls. After the treatment with high does methylprednisolone, the serum TPO levels decrease gradually along with the elevation of platelets. The c MPL mRNA levels in platelets increased with the decrease of PAIgG levels. Conclusion The platelet quantity might regulate the serum TPO level. The down regulated transcription of c MPL mRNA might cause maturity disturbance of megakaryocytes and decrease production of platelets, which may be one of the important factors in the pathogenesis of AITP.
出处 《中华儿科杂志》 CSCD 北大核心 2000年第4期217-219,共3页 Chinese Journal of Pediatrics
关键词 紫癜 血小板减少性 血小板生成素 受体 儿童 Purpura thrombocytopenic idiopathic Thrombopoietin Transcription genetic
  • 相关文献

参考文献2

  • 1张之南,血液病诊断及疗效标准(第2版),1998年,279页
  • 2Chang F Y,Blood,1997年,90卷,增刊,140页

同被引文献58

  • 1赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量:102
  • 2李军民,沈志祥,王振义,黄秋爱,钱六妹,熊树民,杜心,蔡敬仁,陈淑蓉.成人慢性血小板减少性紫癜患者骨髓巨核细胞的研究[J].中华血液学杂志,1994,15(5):251-253. 被引量:35
  • 3俞智华,陆德炎,陈唤青,吴芳颐,杨锦媛.ITP患者的异常免疫对骨髓巨核祖细胞的影响[J].南通医学院学报,1996,16(2):178-179. 被引量:9
  • 4余振玉 余国文.骨髓巨核细胞象之研究[J].中华内科杂志,1960,(5):428-428.
  • 5张之南 忱悌.血液病诊断及疗效标准(第2版)[M].北京:科学出版社,1999.270-271.
  • 6Rodeghiero F, Stasi R, Gemsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an intemational working group. Blood, 2009, 113: 2386-2393.
  • 7Terrell DR, Beebe LA, Vesely SK, et al. The incidence of immune thrombocytopenie purpura in children and adults: a critical review of published reports. Am J Hematol, 2010, 85: 174-180.
  • 8Beardsley DS. ITP in the 21st century. Hematol Am Soc Hematol Educ Program, 2006: 402-407.
  • 9Heyns AP, Lotter MG, Badenhorst PN, et al Kinetics and sites of destruction of l 11-indium oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study. Am J Hematol, 1982, 12: 167-177.
  • 10Stoll D, Cines DB, Aster RH, et al. Platelet kinetics in patients with idiopathic thrombocytcpenic purpura and moderate thrombocytopenia. Blood, 1985, 65: 584-588.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部